Real-world use and effectiveness of adjuvant trastuzumab in 2665 consecutive breast cancer patients

被引：0
|
作者：
Tjan-Heijnen, V. C. G.
Seferina, S. C.
Lobbezoo, D. J. A.
Voogd, A. C.
Dercksen, M. W.
van den Berkmortel, F.
van Kampen, R. J. W.
van de Wouw, A. J.
Joore, M. A.
Borm, G. F.
机构：
[1] Maastricht Univ, Med Ctr, NL-6200 MD Maastricht, Limburg, Netherlands
[2] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, NL-6200 MD Maastricht, Limburg, Netherlands
[3] Maxima Med Ctr, Veldhoven, Brabant, Netherlands
[4] Atrium Med Ctr Parkstad, Heerlen, Limburg, Netherlands
[5] Orbis Med Ctr, Sittard Geleen, Limburg, Netherlands
[6] VieCuri Med Ctr, Venlo, Limburg, Netherlands
[7] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Gelderland, Netherlands
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/0008-5472.SABCS-12-P5-21-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-21-04
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Real-world effectiveness outcomes by race in patients with metastatic triple negative breast cancer
    Skinner, K. E.
    Dufour, R.
    Haiderali, A.
    Huang, M.
    Schwartzberg, L. S.
    CANCER RESEARCH, 2019, 79 (04)
  • [22] Outcomes of real-world use of eribulin plus trastuzumab for HER2-positive metastatic breast cancer
    Mougalian, S. S.
    Copher, R.
    McAllister, L.
    Radtchenko, J.
    Wang, E. C.
    Broscious, M.
    Yu, H-T
    Kish, J.
    CANCER RESEARCH, 2019, 79 (04)
  • [23] Trastuzumab-Related Cardiotoxicity in Adjuvant Setting: A Real-World Scenario
    Shrivastva, Sarita
    Bala, Stalin Chowdary
    Chennamaneni, Rachana
    Konatam, Meher Lakshmi
    Pydi, Venkateswara Rao
    Prasad, Kuruva Siva
    Gundeti, Sadashivudu
    SOUTH ASIAN JOURNAL OF CANCER, 2023, 12 (03) : 233 - 237
  • [24] Real-world evidence of the effectiveness of adjuvant chemotherapy for early stage breast cancer from Scottish routine data
    Hall, Peter S.
    Gray, Ewan
    Marti, Joachim
    Brewster, David
    Wyatt, Jeremy
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [25] Real-world evidence of the effectiveness of adjuvant chemotherapy for early stage breast cancer from Scottish routine data
    Gray, Ewan
    Marti, Joachim
    Brewster, David
    Wyatt, Jeremy
    Hall, Peter
    BRITISH JOURNAL OF CANCER, 2018, 119 (11) : 36 - 37
  • [26] A prospective real-world study to assess the effectiveness and safety of trastuzumab biosimilar in the adjuvant treatment of HER2-positive breast cancer: Preliminary safety results.
    Ferreira Cardoso, Ana Carolina
    Gagliato, Debora De Melo
    Brito, Natalia Mesquita
    Lapa, Maura Gonzaga
    Cavalcanti Santos, Renata Virginia
    Magaton, Erida
    Castilho, Vivienne Carduz
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [27] A prospective real-world study to assess the effectiveness and safety of trastuzumab biosimilar in the adjuvant treatment of HER2-positive breast cancer: Preliminary safety results.
    Ferreira Cardoso, Ana Carolina
    Gagliato, Debora De Melo
    Brito, Natalia Mesquita
    Lapa, Maura Gonzaga
    Pinto Magaton, Erida Aparecida
    Cavalcanti Santos, Renata Virginia
    Castilho, Vivienne Carduz
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [28] Trastuzumab biosimilars interchangeability: Preliminary real-world data in neoadjuvant breast cancer setting
    Nunes, Joao Soares
    Prestes, Ana Paula
    Carneiro, Marcela Bechara
    Marra, Ana Claudia Machado
    Marquezini, Isabela Rovel
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [29] Real world evidence of adjuvant trastuzumab in HER2 positive early breast cancer
    Lluch-Gomez, J.
    Nunez-Alvarez, V.
    de la Torre-Hita, C.
    Bernal-Gomez, M.
    Campini-Bermejo, A.
    Perdomo-Zaldivar, E.
    Rodriguez-Perez, L.
    Calvete-Candenas, J.
    Martinez-Bautista, M. J.
    Benitez-Rodriguez, E.
    Baena-Canada, J. M.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [30] Real world evidence of adjuvant trastuzumab in HER2 positive early breast cancer
    J. Lluch-Gómez
    V. Núñez-Álvarez
    C. de la Torre-Hita
    M. Bernal-Gómez
    A. Campini-Bermejo
    E. Perdomo-Zaldívar
    L. Rodríguez-Pérez
    J. Calvete-Candenas
    M. J. Martínez-Bautista
    E. Benítez-Rodríguez
    J. M. Baena-Cañada
    Scientific Reports, 13
12345